Emerging Technology Partners Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 1
Professionals
  • Investments
  • 61
  • Portfolio
  • 20
  • Exits
  • 34
Exits

Emerging Technology Partners General Information

Description

Founded in 2000, Emerging Technology Partners is a venture capital firm and is based in South San Francisco, California. The firm provides capital to companies making diagnostic and therapeutic products in the fields of life sciences.

Contact Information

Website
www.etpvc.com
Year Founded
2000
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 425 Eccles Avenue
  • South San Francisco, CA 94080
  • United States

Emerging Technology Partners Investments (61)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
YourBio Health 02-Sep-2021 Later Stage VC 0000 Other Devices and Supplies Generating Revenue
00000000 31-Aug-2021 00000 00000 000.00 Diagnostic Equipment Generating Revenue
0000.00 01-Aug-2021 00000 00000 Other Healthcare Technology Systems Generating Revenue
00000 01-Aug-2021 00000 00000 Monitoring Equipment Pre-Clinical Trials
0000000 000000 000 10-Jun-2021 00000 00000 00.00 Enterprise Systems (Healthcare) Generating Revenue
0000000 000000 16-Apr-2021 00000 00000 000.00 Other Healthcare Technology Systems Generating Revenue
0000000 0000000 26-Mar-2021 00000 00000 00.00 Diagnostic Equipment Generating Revenue
0000000 01-Jan-2021 00000 00000 Other Healthcare Services Generating Revenue
Juventas Biology 19-Nov-2020 Early Stage VC 000.00 Drug Discovery Generating Revenue
Gain Therapeutics 11-Jul-2020 Later Stage VC 0000 Drug Discovery Pre-Clinical Trials
You’re viewing 10 of 61 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Emerging Technology Partners Exits (34)

Company Name Exit Date Exit Type Exit Size
Gain Therapeutics 18-Mar-2021 IPO 0000
0000 000000000 14-Dec-2020 000000000000000000 00.000
00000000 000000 15-Jun-2020 000 00000
00000000 00000000 05-Feb-2020 000000000 00000000 000.00
000000000000 15-Jan-2020 000000000000000000
0000000 0000000000 14-May-2019 000 0000
0000000 00000000 21-Sep-2018 000 000.00
00000 000000000000 01-Dec-2017 000000000000000000 00000
NexImmune 14-Feb-2017 Buyout/LBO
Origene 13-Feb-2017 Merger/Acquisition
You’re viewing 10 of 34 exits. Get the full list »

Emerging Technology Partners Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Emerging Technology Partners Team (7)

Name Title Deals Funds Boards Office
Wei-Wu He Ph.D Co-Founder & General Partner 00 0 0 Rockville, MD
Frank Bonsal Jr. Advisor 0 0 0 Rockville, MD
Joel Marcus JD Advisor 00 0 00 Rockville, MD
Nancy Chang Ph.D Advisor 0 0 0 Rockville, MD
Steven Frank Advisor 0 0 Rockville, MD
You’re viewing 5 of 7 team members. Get the full list »

Emerging Technology Partners Co-Investors (72)

Name With Exits Lead Partner Series Industry
Delian Capital 2 Series chart Industry bar
Health Nucleus 0 0 Series chart Industry bar
Human Longevity and Performance Impact Venture Fund 0 0 0 Series chart Industry bar
Alafi Capital Company 0 Series chart Industry bar
Paladin Capital Group 0 0 Series chart Industry bar
You’re viewing 5 of 72 co-investors. Get the full list »